Furthermore, FOXP4 expression in both alveolar and immune cells in the lung, and the association with severe COVID-19 and pulmonary diseases such as cancer, suggests that FOXP4 may participate in local immune responses in the lung. Here, FOXP4 is linked to COVID-19.